Bdxtiotech Analysts Tewari and Raycroft, along with Dr. Kevin M. Alexander, discuss how will TTR silencers impact Vyndagel use on an Analyst/Industry conference call to be held on June 7 at 12 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Relay teams with with Pfizer for RLY-2608/atirmociclib combo evaluation for BC
- Olema Oncology price target raised to $30 from $21 at Oppenheimer
- Here’s Why Novavax Stock (NVAX) Gained Over 21% Yesterday
- GSK (NYSE:GSK) Nosedives Amid Zantac Lawsuits Tsunami
- Pfizer presents detailed data from Phase 3 ECHELON-3 study
Questions or Comments about the article? Write to editor@tipranks.com